Treatment response of cystic echinococcosis to benzimidazoles: a systematic review.

Over the past 30 years, benzimidazoles have increasingly been used to treat cystic echinococcosis (CE). The efficacy of benzimidazoles, however, remains unclear. We systematically searched MEDLINE, EMBASE, SIGLE, and CCTR to identify studies on benzimidazole treatment outcome. A large heterogeneity...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marija Stojkovic, Marcel Zwahlen, Antonella Teggi, Kamenna Vutova, Carmen M Cretu, Roberto Virdone, Polyxeni Nicolaidou, Nazan Cobanoglu, Thomas Junghanss
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2009
Materias:
Acceso en línea:https://doaj.org/article/d1f8f5f9875a4bf687005f952e07ccf3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d1f8f5f9875a4bf687005f952e07ccf3
record_format dspace
spelling oai:doaj.org-article:d1f8f5f9875a4bf687005f952e07ccf32021-12-02T20:23:52ZTreatment response of cystic echinococcosis to benzimidazoles: a systematic review.1935-27271935-273510.1371/journal.pntd.0000524https://doaj.org/article/d1f8f5f9875a4bf687005f952e07ccf32009-09-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19787039/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735Over the past 30 years, benzimidazoles have increasingly been used to treat cystic echinococcosis (CE). The efficacy of benzimidazoles, however, remains unclear. We systematically searched MEDLINE, EMBASE, SIGLE, and CCTR to identify studies on benzimidazole treatment outcome. A large heterogeneity of methods in 23 reports precluded a meta-analysis of published results. Specialist centres were contacted to provide individual patient data. We conducted survival analyses for cyst response defined as inactive (CE4 or CE5 by the ultrasound-based World Health Organisation [WHO] classification scheme) or as disappeared. We collected data from 711 treated patients with 1,308 cysts from six centres (five countries). Analysis was restricted to 1,159 liver and peritoneal cysts. Overall, 1-2 y after initiation of benzimidazole treatment 50%-75% of active C1 cysts were classified as inactive/disappeared compared to 30%-55% of CE2 and CE3 cysts. Further in analyzing the rate of inactivation/disappearance with regard to cyst size, 50%-60% of cysts <6 cm responded to treatment after 1-2 y compared to 25%-50% of cysts >6 cm. However, 25% of cysts reverted to active status within 1.5 to 2 y after having initially responded and multiple relapses were observed; after the second and third treatment 60% of cysts relapsed within 2 y. We estimated that 2 y after treatment initiation 40% of cysts are still active or become active again. The overall efficacy of benzimidazoles has been overstated in the past. There is an urgent need for a pragmatic randomised controlled trial that compares standardized benzimidazole therapy on responsive cyst stages with the other treatment modalities.Marija StojkovicMarcel ZwahlenAntonella TeggiKamenna VutovaCarmen M CretuRoberto VirdonePolyxeni NicolaidouNazan CobanogluThomas JunghanssPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 3, Iss 9, p e524 (2009)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Marija Stojkovic
Marcel Zwahlen
Antonella Teggi
Kamenna Vutova
Carmen M Cretu
Roberto Virdone
Polyxeni Nicolaidou
Nazan Cobanoglu
Thomas Junghanss
Treatment response of cystic echinococcosis to benzimidazoles: a systematic review.
description Over the past 30 years, benzimidazoles have increasingly been used to treat cystic echinococcosis (CE). The efficacy of benzimidazoles, however, remains unclear. We systematically searched MEDLINE, EMBASE, SIGLE, and CCTR to identify studies on benzimidazole treatment outcome. A large heterogeneity of methods in 23 reports precluded a meta-analysis of published results. Specialist centres were contacted to provide individual patient data. We conducted survival analyses for cyst response defined as inactive (CE4 or CE5 by the ultrasound-based World Health Organisation [WHO] classification scheme) or as disappeared. We collected data from 711 treated patients with 1,308 cysts from six centres (five countries). Analysis was restricted to 1,159 liver and peritoneal cysts. Overall, 1-2 y after initiation of benzimidazole treatment 50%-75% of active C1 cysts were classified as inactive/disappeared compared to 30%-55% of CE2 and CE3 cysts. Further in analyzing the rate of inactivation/disappearance with regard to cyst size, 50%-60% of cysts <6 cm responded to treatment after 1-2 y compared to 25%-50% of cysts >6 cm. However, 25% of cysts reverted to active status within 1.5 to 2 y after having initially responded and multiple relapses were observed; after the second and third treatment 60% of cysts relapsed within 2 y. We estimated that 2 y after treatment initiation 40% of cysts are still active or become active again. The overall efficacy of benzimidazoles has been overstated in the past. There is an urgent need for a pragmatic randomised controlled trial that compares standardized benzimidazole therapy on responsive cyst stages with the other treatment modalities.
format article
author Marija Stojkovic
Marcel Zwahlen
Antonella Teggi
Kamenna Vutova
Carmen M Cretu
Roberto Virdone
Polyxeni Nicolaidou
Nazan Cobanoglu
Thomas Junghanss
author_facet Marija Stojkovic
Marcel Zwahlen
Antonella Teggi
Kamenna Vutova
Carmen M Cretu
Roberto Virdone
Polyxeni Nicolaidou
Nazan Cobanoglu
Thomas Junghanss
author_sort Marija Stojkovic
title Treatment response of cystic echinococcosis to benzimidazoles: a systematic review.
title_short Treatment response of cystic echinococcosis to benzimidazoles: a systematic review.
title_full Treatment response of cystic echinococcosis to benzimidazoles: a systematic review.
title_fullStr Treatment response of cystic echinococcosis to benzimidazoles: a systematic review.
title_full_unstemmed Treatment response of cystic echinococcosis to benzimidazoles: a systematic review.
title_sort treatment response of cystic echinococcosis to benzimidazoles: a systematic review.
publisher Public Library of Science (PLoS)
publishDate 2009
url https://doaj.org/article/d1f8f5f9875a4bf687005f952e07ccf3
work_keys_str_mv AT marijastojkovic treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview
AT marcelzwahlen treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview
AT antonellateggi treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview
AT kamennavutova treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview
AT carmenmcretu treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview
AT robertovirdone treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview
AT polyxeninicolaidou treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview
AT nazancobanoglu treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview
AT thomasjunghanss treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview
_version_ 1718374135058399232